In addition, resveratrol can also alleviate NAFLD-induced liver damage by inhibiting autophagy and signaling of the IκBα-NF-κB pathway (Li et al., 2014) and downregulating the protein levels of IL-6, IL-1β, and TNF-α (Che et al., 2020). Here, IL1B is linked to metabolic dysfunction-associated steatotic liver disease.